Appili Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	2	4	4	5	9	70
Market Cap Growth	-53.22%	-	-12.50%	-43.28%	-87.73%	120.84%
Enterprise Value	14	15	12	9	2	50
Last Close Price	0.01	0.04	0.04	0.04	0.12	1.11
Forward PE	-	-	-	-	-	3.27
PS Ratio	9.62	42.26	5.13	14.52	6.15	-
PB Ratio	-0.12	-0.32	-0.39	-0.66	-2.61	5.46
P/TBV Ratio	-	-	-	-	-	5.46
P/FCF Ratio	-	4.90	-	-	-	-
P/OCF Ratio	-	4.89	-	-	-	-
EV/Sales Ratio	68.99	152.75	14.08	26.53	1.57	-
EV/FCF Ratio	-	17.71	-	-	-	-
Debt / Equity Ratio	-0.76	-0.92	-0.75	-1.04	-1.52	0.08
Debt / FCF Ratio	-	14.19	-	-	-	-
Net Debt / Equity Ratio	-0.75	-0.83	-0.74	-0.70	0.52	-1.18
Net Debt / EBITDA Ratio	-1.99	-1.10	-1.01	-0.66	0.07	0.97
Net Debt / FCF Ratio	-1080.81	12.77	-3.24	-0.51	0.09	1.32
Asset Turnover	0.16	0.04	0.36	0.06	0.11	-
Quick Ratio	0.02	0.19	0.11	0.97	1.21	3.86
Current Ratio	0.03	0.19	0.13	1.05	1.24	3.96
Return on Equity (ROE)	-	-	-	-	-529.79%	-132.65%
Return on Assets (ROA)	-291.97%	-278.71%	-217.68%	-86.67%	-115.98%	-66.38%
Return on Capital Employed (ROCE)	39.40%	79.70%	80.10%	-5098.10%	-1530.40%	-114.30%
Earnings Yield	-149.26%	-61.84%	-89.08%	-190.55%	-293.71%	-20.56%
FCF Yield	-	20.41%	-58.76%	-208.24%	-223.12%	-16.45%
Buyback Yield / Dilution	-4.39%	-	-6.63%	-70.43%	-12.76%	-72.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.